Brady Kelly
SEC insider (Form 3/4/5 filer). CIK 0002117686. Officer at Seres Therapeutics, Inc. (MCRB). 6 reported Form 4/5 transactions since Sep 2024; latest on Aug 17, 2026. Located in CAMBRIDGE, MA.
Companies Brady Kelly has filed insider reports for
- Seres Therapeutics, Inc. (MCRB): Officer, See Remarks
Brady Kelly
CIK: 0002117686
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Seres Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Aug 17, 2026MCRB
Seres Therapeutics, Inc.
SaleDirect64 shares at avg. $4.55$291.2 - Aug 15, 2026MCRB
Seres Therapeutics, Inc.
ExerciseDirect181 shares- - Jul 8, 2026MCRB
Seres Therapeutics, Inc.
AwardDirectStock Option (right to buy)
18.8K shares- - May 18, 2026MCRB
Seres Therapeutics, Inc.
SaleDirect59 shares at avg. $7.53$444.27 - May 15, 2026MCRB
Seres Therapeutics, Inc.
ExerciseDirect180 shares- - Mar 4, 2026MCRB
Seres Therapeutics, Inc.
AwardDirectStock Option (right to buy)
56.3K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 17, 2026 | MCRB Seres Therapeutics, Inc. | Sale | 64 | $4.55 | $291 | Direct |
| Aug 15, 2026 | MCRB Seres Therapeutics, Inc. | Exercise | 181 | - | $0 | Direct |
| Jul 8, 2026 | MCRB Seres Therapeutics, Inc. | Award Stock Option (right to buy) | 18,750 | - | - | Direct |
| May 18, 2026 | MCRB Seres Therapeutics, Inc. | Sale | 59 | $7.53 | $444 | Direct |
| May 15, 2026 | MCRB Seres Therapeutics, Inc. | Exercise | 180 | - | $0 | Direct |
| Mar 4, 2026 | MCRB Seres Therapeutics, Inc. | Award Stock Option (right to buy) | 56,250 | - | - | Direct |
1-6 of 6 transactions